Genus Ziziphus for the treatment of chronic inflammatory diseases

Abstract

Natural products and traditional medicine are rich sources for developing therapeutics for chronic inflammatory diseases. However, the way from natural products/traditional medicines to Western pharmaceutical practices is not always straightforward. According to the World Health Organization (WHO), chronic diseases are the greatest threat to human health. 3 of 5 people die due to chronic inflammatory disorders worldwide like chronic respiratory diseases, stroke, cardiovascular diseases, cancer, diabetes, and obesity. Various nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce inflammation and pain, but there are many side effects of these drugs' administration. Medicinal plants have therapeutic anti-inflammatory effects with low or no side effects. <i>Ziziphus</i> plant species are generally safe and not toxic to humans. Many studies on the <i>Ziziphus</i> species have shown that their therapeutic properties are attributed to the roots, leaves and fruits. Unfortunately, <i>Ziziphus</i> species from different regions worldwide with anti-inflammatory properties have not been documented in a single review paper. Therefore, it is crucial to establish ethnobotanical knowledge and applications of <i>Ziziphus</i> species against chronic inflammatory diseases. The current article exhaustively reviews phytochemical profile, pharmacological studies, toxicological effects, and ethnobotanical uses of Genus <i>Ziziphus</i> in chronic anti-inflammatory diseases. The present review article also highlights the most promising experimental data on <i>Ziziphus</i> extracts and pure compounds active in clinical trials and animal models of chronic inflammatory diseases. This review would be a valuable resource for contemporary researchers in the field to understand the promising role of the <i>Ziziphus</i> genus in chronic inflammatory disorders.